Pope Francis (Credit: X)
Pope Francis injured his right arm after suffering a fall earlier this week. According to the Vatican, while the 88-year-old pontiff did not break his arm, a sling was put on as a precaution. This incident comes just weeks after another fall on December 7, where he hit his chin on a nightstand, resulting in another, visible bruise. The pope's health has been a topic of ongoing speculation due to his age and medical history, which includes long bouts of bronchitis and mobility challenges. Often seen using a wheelchair or a cane, Francis also uses a walker within the Vatican's Santa Marta hotel, where he resides. Notably, his frailty has brought renewed attention to the risks of falls among elderly individuals and the steps one must follow to mitigate such falls.
A study published in Frontiers in Aging Neurosciences people get older, the bone density in the lower back and thigh bone decreases significantly. This raises the risk of osteoporosis (OP). Therefore it becomes pivotal to pay early attention to nutrition, exercise ability, vitamin D levels, and uric acid levels in older individuals to prevent Ostreopsis and mitigate fall risks. The risk of falls and bone injuries among elderly individuals underscores the importance of preventive measures for maintaining bone health and minimizing fall risks.
Elderly, particularly menopausal women, require a daily calcium intake of 1,200 mg, divided into two or more doses. This can be achieved through dietary sources such as dairy and non-dairy products or through supplements like calcium carbonate and calcium citrate. However, total daily calcium intake should not exceed 2,500 mg to avoid potential health risks.
Vitamin D is essential for calcium absorption and bone mineralization. While sunlight exposure helps synthesize vitamin D, older individuals often require supplements due to reduced skin synthesis and the limited availability of foods. Fortified milk and supplements containing 200–600 IU of vitamin D daily are recommended, with higher doses required for those with deficiencies. Severe cases may necessitate high-dose treatments, such as 50,000 IU weekly for up to three months, along with regular monitoring of calcium and vitamin D levels.
Regular exercise is vital for preserving bone mass and reducing fall risk. Weight-bearing activities, strength training, and balance exercises like brisk walking or skipping can enhance bone density and improve coordination. Experts recommend at least 30 minutes of moderate physical activity most days of the week, supplemented by strength training twice weekly. For individuals unable to engage in standard exercise routines, alternatives like vibrating platforms may help maintain bone health.
Falls remain a leading cause of fractures among individuals over 60. Addressing contributing factors such as balance issues, vision problems, and environmental hazards can significantly reduce risks. Preventive measures include regular vision checks, minimizing medications causing dizziness, improving home safety (e.g., installing railings and removing loose rugs), and wearing rubber-soled footwear. Hip protectors may also help mitigate the impact of falls.
Credit: AI
Michigan health officials say that they may have identified the possible source behind one of the largest Cyclosporiasis outbreaks the state has ever recorded. Thousands of people were sickened by a parasitic infection that can cause severe, watery, or even “explosive” diarrhea.
On July 13, the Michigan Department of Health and Human Services (MDHHS) announced preliminary findings from its investigation point to lettuce or other salad greens as the possible source of Cyclospora outbreak.
However, officials stressed that the investigation is in progress, and no specific product, grower, distributor, or supplier has yet been identified for certain.
Health officials also interviewed more than 1,000 patients to identify common exposures.
Early analysis also repeatedly identified lettuce and salad greens as foods consumed before illness, prompting the state to issue precautionary guidance while the investigation continues.
"Although we do not have a definite product identified as the source of the outbreak, we want to let Michiganders know what we have learned so far so they can take steps to protect their families," said Dr. Natasha Bagdasarian, Michigan's chief medical executive, in a state statement.
The outbreak has continued to expand at an extraordinary pace since late June. As of July 13, Michigan reported 2,640 cases of Cyclosporiasis, with 44 hospitalizations.
No deaths have been reported so far. The number represents a dramatic increase from the state's usual annual number, which is around 40 to 50 cases.
Cyclospora is a parasite that infects people after they consume food or water contaminated with human feces containing the parasite's eggs (oocysts).
Although the illness is usually not life-threatening, it can cause prolonged diarrhea, stomach cramps, nausea, fatigue, bloating, and weight loss.
According to recent reports, fresh produce like salad greens and lettuce are being considered the most common source of infection, though contaminated water can also spread the parasite.
Also read: Explosive Diarrhea Parasite Spreads Across US: Why CDC Is Unable To Find The Source?
Health officials have advised people to avoid fresh produce. Previous Cyclospora outbreaks in the US have frequently been linked to imported fresh produce, including:
While washing produce cannot eliminate all risks, experts say it can reduce contamination. They advised washing fruits and vegetables thoroughly under clean running water and washing hands before and after handling fresh produce.
According to the Michigan Department of Health and Human Services, cooking produce whenever possible during an active outbreak is crucial, as heating food to at least 158°F (70°C) kills Cyclospora.
For specific produce, it suggested:
Credit: AI
Due to climate change, the range of disease-carrying ticks across Canada have increased. Health experts have recently warned about a lesser-known infection that is spreading across the country rapidly. It is called anaplasmosis.
For years, Lyme disease has dominated conversations around tick bites. Experts are now saying that another illness transmitted by the same black-legged tick is spreading into new regions as warmer temperatures create favorable conditions for ticks to thrive.
The warning comes after a recently published report in the Canadian Medical Association Journal (CMAJ) highlighted anaplasmosis as an emerging disease in Canada. Experts urged healthcare providers to diagnose it early as delayed treatment can lead to severe complications.
The report described a patient who developed heart inflammation (myocarditis), after contracting the infection, highlighting the fact that while many cases are mild, some can become life-threatening.
Anaplasmosis is caused by the bacterium Anaplasma phagocytophilum. It is transmitted through the bite of infected black-legged ticks (Ixodes scapularis) and western black-legged ticks (Ixodes pacificus).
Unlike Lyme disease, which primarily affects the skin, joints and nervous system, anaplasmosis infects white blood cells, weakening the body's immune system.
The symptoms of anaplasmosis commonly develop within one to two weeks after a tick bite and often resemble the flu. They include:
Also read: Bella Hadid Opens Up About Challenges Of Living With Lyme Disease
Warmer and longer spring and summer and shorter winters are creating the ideal breeding grounds for black-legged ticks. These ticks are expanding farther north into regions where they previously could not survive.
At the same time, warmer conditions are extending the period during which ticks remain active. Public health officials say that ticks can now be active whenever temperatures remain consistently above freezing.
The Public Health Agency of Canada has reported that the geographic range of ticks carrying diseases such as Lyme disease, anaplasmosis and babesiosis continues to expand across several provinces, including Ontario, Quebec, Manitoba, New Brunswick and parts of Atlantic Canada.
Although many people recover completely with prompt treatment, anaplasmosis, if left untreated, can cause serious complications affecting the lungs, kidneys, nervous system and heart.
Older adults, people with weakened immune systems and those whose treatment is delayed face the highest risk of severe illness.
Canadian health authorities recommend that treatment begin as soon as doctors suspect anaplasmosis rather than waiting for laboratory confirmation, since early intervention significantly improves outcomes.
Protecting yourself during tick season is one of the ways to ward off risk of infection. Health officials recommend several simple precautions to reduce the risk of tick bites:
As Canada's climate continues to warm, experts say the country's tick-borne disease landscape is changing rapidly. While Lyme disease remains the most recognized threat, physicians warn that anaplasmosis is no longer a rare infection.
Credit: AI
A new safety analysis has found that Wegovy, the recently launched blockbuster weight loss medication containing semaglutide, may cause a rare but dangerous eye condition that can lead to sudden and permanent vision loss.
The analysis, published in the British Journal of Ophthalmology, compared Wegovy, semaglutide tablets and other GLP-1 drugs like Ozempic by examining more than 30 million reports from the U.S. Food and Drug Administration's Adverse Event Reporting System (FAERS) submitted between 2017 and 2024.
Scientists found a safety signal that linked semaglutide medicines to non-arteritic anterior ischemic optic neuropathy (NAION), also known as eye stroke.
The signal appeared to be nearly five times stronger for Wegovy than for Ozempic, despite both medicines containing the same active ingredient, semaglutide.
NAION occurs when blood flow to the optic nerve suddenly gets reduced, causing damage to the nerve responsible for transmitting visual information from the eye to the brain. The patient experiences painless vision loss in one eye.
While some patients experience partial improvement, the vision loss is frequently permanent. There is currently no proven treatment to reverse the damage.
Researchers state that the findings do not prove that Wegovy causes NAION. Instead, they observe a typical signal, meaning an unexpected pattern observed in a large safety database that requires immediate further investigation.
Such pharmacological analyses are useful for identifying rare and adverse side effects that may not emerge during clinical trials.
Also read: Novo Nordisk Launches Awiqli In India: All About The World's First Once-Weekly Insulin
The stronger link observed with Wegovy and NAION compared with Ozempic has also raised new questions. Both drugs contain semaglutide, but Wegovy is prescribed at higher doses for obesity, while Ozempic is used to treat type 2 diabetes.
Researchers say that factors such as higher dosing, differences in patient populations, or underlying health conditions could help explain the disparity, although more research is needed.
The latest findings build on growing scientific interest in the potential eye-related risks of GLP-1 receptor agonists.
Previous observational studies have also reported an increased risk of NAION among semaglutide users, prompting regulators in Europe to add the condition as a very rare side effect to semaglutide product information last year.
Health experts emphasize that patients should not stop taking Wegovy without consulting their healthcare provider. For most users, the drug's benefits in managing obesity and reducing associated health risks are likely to outweigh the extremely rare risk of developing NAION.
However, anyone taking Wegovy who experiences sudden blurred vision or loss of vision should seek immediate medical attention.
The GLP-1 medication industry is in a boom. Novo Nordisk, the maker of GLP-1 medicines like Ozempic and Wegovy, is currently exploring a new way to deliver weight-loss treatment that could reduce the need for weekly injections.
The implant, known as NPM-139, is a miniature device developed using Vivani Medical's proprietary NanoPortal technology. Rather than requiring patients to inject semaglutide every week, the tiny implant is placed beneath the skin and slowly releases the medication over an extended period.
If successful, it could mark a significant step toward making GLP-1 drug more convenient for people living with obesity.
© 2024 Bennett, Coleman & Company Limited